Hot news

  • Experts See Narrow Window Of Opportunity For Japan TPP Breakthrough

    Experts this week held out the possibility that Japan and the U.S. could still reach a breakthrough agreement by the end of September that would ultimately allow Japan to enter the ongoing Trans-Pacific Partnership (TPP) negotiations. However, they conceded that a variety of political factors make the likelihood of such a breakthrough unclear, and agreed that Prime Minister Yoshihiko Noda is still unable to fully focus his attention on the issue of TPP entry.

  • Mexico to join Trans-Pacific Partnership talks

    (Reuters) - The United States and eight other countries on Monday welcomed Mexico into talks aimed at reaching an Asia Pacific free trade agreement, but continued to mull over Canada and Japan's seven-month-old bids to join the negotiations.

  • Canada to join Trans-Pacific trade talks

    LOS CABOS, Mexico, June 19 (Reuters) - Canada will join 10 other nations in talks aimed at creating an Asia Pacific free trade agreement, Prime Minister Stephen Harper announced on Tue sday, part of a bid to reduce reliance on the U.S. market in favor of fast-growing emerging economies.

  • Leaked TPP Text Shows Disagreement On Indirect Expropriation Definition

    The draft investment text in the Trans-Pacific Partnership (TPP) negotiations, which was leaked yesterday (June 13) by a U.S. civil society group, reveals that TPP countries are offering up radically different visions when it comes defining when a specific government action constitutes "indirect expropriation" of a company's property.

  • The Trans-Pacific Partnership and Asia-Pacific Integration: A Quantitative Assessment

    Since the conclusion of the Uruguay Round the development of international trade rules has drifted from global to regional and bilateral agreements. The United States has not participated actively in this shift and the Trans-Pacific Partnership (TPP), now in negotiation, could become its first significant regional agreement since the North American Free Trade Agreement (NAFTA). The TPP is also a possible pathway to the larger Free Trade Area of the Asia-Pacific (FTAAP). This study examines the potential benefits and costs of the TPP and its strategic implications for economic integration in the Asia-Pacific.

  • U.S.-Korea Free Trade Agreement Enters in to Force

    The U.S.-Korea Free Trade Agreement (Agreement) entered into force on March 15, 2012. One of the Agreement’s principal benefits is reduced duties on originating goods traded between the United States and the Republic of Korea (Korea).

  • USTR Tables TPP Labor Proposal that goes beyond May 10 template

    The complete labor proposal tabled by the Office of the U.S. Trade Representative in the Trans-Pacific Partnership (TPP) negotiations late last month has aroused the ire of congressional Republicans, who object to the fact that it goes beyond the labor provisions included in the so-called May 10, 2007, template.The proposal, which remains confidential, does not alter the fundamental standards contained in the May 10 template, according to informed sources.

  • Declaration of the Vietnam Network of People Living with HIV/AIDS on the TPP & Access to medicines

    "The Vietnamese Government is negotiating a Trans-Pacific Partnership (TPPA) free trade agreement in with the US, Australia, New Zealand, Chile, Peru, Brunei, Singapore, Malaysia and Vietnam. We, the undersigned, declare our opposition to the TPPA as it puts the profits of multinational pharmaceutical companies ahead of the people’s right to health...."

  • Dangers for Access to Medicines in the Trans-Pacific Partnership Agreement: Comparative Analysis of the U.S. Intellectual Property Proposal and Vietnamese Law

    A comparision between a Leaked U.S. TPPA Proposal and Vietnamese Law On Intellectual Property

  • New Trade Deal Would Benefit Big Pharma At AIDS Programs' Expense

    According to leaked documents from the talks, U.S. negotiators are seeking to impose a set of restrictive intellectual property laws that would help American drug companies secure long-term monopolies overseas. The result? Higher prices for drugs. That's good for corporate profits, but disastrous for relief programs like PEPFAR that depend on cheaper generic medications to treat the global poor.